Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM56 (TRIM56)

Target
TRIM56
Molecular classification
E3 ubiquitin ligase, RING finger protein, Tripartite motif-containing protein
01

Overview

E3 ubiquitin-protein ligase TRIM56 (TRIM56) is a member of the tripartite motif (TRIM) family and contains a RING domain, B-box domains, a coiled-coil region, and a C-terminal segment essential for its function[1][3][4][5]. TRIM56 acts primarily as an E3 ubiquitin ligase, facilitating the transfer of ubiquitin from E2 enzymes to substrate proteins, thereby regulating their stability, signaling, or localization—a process important for innate immunity, antiviral defense, and cellular homeostasis[1][3][4]. It mediates the K63-linked ubiquitination of STING and monoubiquitinates cGAS, amplifying production of type I interferons and antiviral cytokines in response to dsDNA viruses[1][4]. TRIM56 restricts replication of bovine viral diarrhea virus, dengue virus, yellow fever virus, and porcine epidemic diarrhea virus in an E3 ligase-dependent manner[1][2][5]. In cancer, TRIM56 has dual roles, suppressing ovarian cancer by promoting vimentin degradation, but supporting breast cancer cell proliferation by stabilizing estrogen receptor α[1]. Its gene is inducible by interferon and virus, and its protein expression is regulated by both transcriptional and post-translational events[2][4][5]. Structural studies indicate that TRIM56 assembles into an antiparallel tetramer via its coiled-coil domain, creating a scaffold that facilitates substrate recruitment and ubiquitin transfer activity[1][3].

Other names
Tripartite motif-containing protein 56RING finger protein 109RNF109RING-type E3 ubiquitin transferase TRIM56
02

Mechanism of action

Not applicable due to lack of direct drug interactions; TRIM56 itself mediates ubiquitination of select proteins involved in antiviral and cellular signaling pathways.

03

Biological functions

Innate immune responseProtein ubiquitinationSignal transductionRegulation of viral restriction and antiviral immunityCell proliferationProtein degradation
04

Disease associations

CancerInfection (antiviral defense, e.g., against pestiviruses, dengue, and yellow fever virus)Other (modulation of immune signaling pathways)
05

Biomarkers

Interferon-stimulated gene expression

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM56 (TRIM56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM56 (TRIM56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call